PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26949064-11	2016	Clofibrate minimized changes in MCAD, CYP4A, PGC-1alpha and ERRalpha expressions with increased PPARalpha, very long-chain acyl-CoA dehydrogenase (VLCAD) and long-chain acyl-CoA dehydrogenase (LCAD) expressions.	Clofibrate	0-10	acyl-CoA dehydrogenase medium chain	Rattus norvegicus	32-36	
17352811-6	2007	In addition, in both experiments fetuses of the oxidized fat group and the clofibrate group also had markedly higher relative mRNA concentrations of ACO, CYP4A1, CPT I, MCAD, and LCAD in the liver than those of the control group (P < 0.05), whereas the relative mRNA concentrations of PPARalpha, SREBP-1c, and FAS did not differ between treatment groups.	Clofibrate	75-85	acyl-CoA dehydrogenase medium chain	Rattus norvegicus	169-173	
15018640-7	2004	Similarly, clofibrate and WY14643 increased expression of MCAD, a downstream target protein of PPARalpha by 123 +/- 8% (p < 0.05) and 143 +/- 8% (p < 0.05), respectively.	Clofibrate	11-21	acyl-CoA dehydrogenase medium chain	Rattus norvegicus	58-62